A 36-year-old woman with prior hypertriglyceridemia-induced pancreatitis presented with a recurrence of pancreatitis after beginning in vitro fertilization (IVF). Her primary care physician had discontinued fenofibrate due to concerns for teratogenicity. This case illustrates the importance of fibrate therapy for high-risk women undergoing IVF, despite limited evidence regarding its teratogenicity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097723 | PMC |
| http://dx.doi.org/10.1002/ccr3.5874 | DOI Listing |
Publication Analysis
Top Keywords
hypertriglyceridemia-induced pancreatitis
8
vitro fertilization
8
pancreatitis egg
4
egg retrieval
4
retrieval vitro
4
fertilization fenofibrate
4
fenofibrate cessation
4
cessation 36-year-old
4
36-year-old woman
4
woman prior
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!